Loading...
Advance of theragnosis biomarkers in lung cancer: from clinical to molecular pathology and biology
One distinct molecular subtype of non-small cell lung cancer (NSCLC) is defined by rearrangement of the anaplastic lymphoma kinase (ALK). The increasing knowledge over the last years has enabled the continuous improvement of ALK inhibitors; however, resistance in these patients remains a major conce...
Na minha lista:
| Udgivet i: | J Thorac Dis |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6353748/ https://ncbi.nlm.nih.gov/pubmed/30775023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.12.03 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|